PharmaTech Recalls Highlight Supplement GMP Diligence For Marketers – CRN

PharmaTech customers recall liquid supplements, including products indicated for children, after CDC informs FDA that an antibiotic-resistant pathogen was found in a PharmaTech Rx drug. CRN says the recall should remind supplement firms about tracking supply chains and auditing contract manufacturers.

The Council for Responsible Nutrition reminds dietary supplement firms about due diligence in tracking supply chains and responding quickly to manufacturing problems following FDA’s warning about the risk of an antibiotic-resistant bacteria in supplements made by contract manufacturer PharmaTech LLC,

The Centers for Disease Control and Prevention recently found a strain of burkholderia cepacian (B. cepacia), a pathogen known for...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Recalls

More from Policy & Regulation